Diabetes Technologies: We Are All in This Together

The United States faces a shortage of both primary care physicians (PCPs) and endocrinologists-the two groups of clinicians who provide the majority of care to people with diabetes (1–3). Patients treated with intensive insulin therapy, including all of those with type 1 diabetes and many with type...

Full description

Saved in:
Bibliographic Details
Published inClinical diabetes Vol. 38; no. 2; pp. 188 - 189
Main Authors Oser, Sean M, Oser, Tamara K
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.04.2020
Subjects
Diabetes
Disease management
Insulin
Primary care
United States > US
Online AccessGet full text

Cover

More Information
Summary:The United States faces a shortage of both primary care physicians (PCPs) and endocrinologists-the two groups of clinicians who provide the majority of care to people with diabetes (1–3). Patients treated with intensive insulin therapy, including all of those with type 1 diabetes and many with type 2 diabetes, face numerous daily self-management decisions. These decisions include factoring insulin dosing, glucose management, diet, activity, and other behavioral factors into their decision-making. These patients stand to gain from using the treatment and monitoring technologies that are rapidly advancing and accumulating evidence in support of their benefits. Despite this situation, the actual use of such technologies, including continuous glucose monitoring (CGM) and closed-loop artificial pancreas systems, remains relatively low (4,5).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0891-8929
1945-4953
DOI:10.2337/cd19-0046